| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.10B | -7.9% |
| Cost of Revenue | $7.26B | -5.9% |
| Gross Profit | $2.84B | -12.8% |
| R&D Expense | $150.0M | +4.2% |
| SG&A Expense | $1.01B | +5.7% |
| Operating Income | $360.0M | -68.1% |
| Interest Expense | $256.0M | +20.8% |
| Pre-tax Income | $104.0M | -88.6% |
| Income Tax | $293.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $345.0M | -4.4% |
| Accounts Receivable | $937.0M | -24.7% |
| Inventory | $1.47B | -7.2% |
| Current Assets | $3.35B | -1.0% |
| Total Assets | $12.98B | -7.8% |
| Current Liabilities | $2.66B | +15.8% |
| Long-term Debt | $5.12B | -0.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.79B | -5.6% |
| Investing Cash Flow | -$765.0M | +77.5% |
| Financing Cash Flow | -$1.07B | -421.0% |
| +6.5% |
| Net Income | -$522.0M | -180.7% |
| EPS (Basic) | -$6.22 | -183.5% |
| EPS (Diluted) | -$6.22 | -184.4% |
| Total Liabilities |
| $9.09B |
| +1.5% |
| Stockholders' Equity | $3.85B | -24.1% |